Weill Cornell Medicine NY-Presb is a clinical research site located in New York, New York, United States 10021.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
Weill Cornell Medicine NY-Presb has participated in 5 clinical trials with 2 currently active.
Therapeutic areas: Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Chronic Myelogenous Leukemia.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Weill Cornell Medicine NY-Presb has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Weill Cornell Medicine NY-Presb has 5 clinical trials on record, with 2 currently active. Their work covers Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Chronic Myelogenous Leukemia.
Weill Cornell Medicine NY-Presb has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.